Paid Clinical Trials for Ulcerative Colitis

Showing 1 – 20 of 42 results

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

by CTG

in Crohn Disease, Ulcerative Colitis, IBD

Other

Ohio

Deadline:

06/30/2026

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

by CTG

in Ulcerative Colitis

Other

California

Deadline:

10/17/2029

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

by CTG

in Multiple Sclerosis, Ulcerative Colitis, Autoimmune Diseases, Scleroderma, Ankylosing Spondylitis

Other

California

Deadline:

01/01/2027

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

by CTG

in Ulcerative Colitis, Obesity or Overweight

Other

Alabama

Deadline:

04/01/2028

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

by CTG

in Ulcerative Colitis

Other

California

Deadline:

10/31/2028

Study of Novel Therapeutics for Acute Remedy of Colitis

by CTG

in Ulcerative Colitis, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe

Other

Massachusetts

Deadline:

06/01/2027

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

by CTG

in Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis, Indeterminate Colitis

Other

Alabama

Deadline:

06/30/2038

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

by CTG

in Ulcerative Colitis

Other

California

Deadline:

03/11/2027

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

by CTG

in Ulcerative Colitis

Other

Arizona

Deadline:

03/01/2029

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

by CTG

in Inflammatory Bowel Diseases, Ulcerative Colitis, Colitis, Ulcerative, Colitis

Other

California

Deadline:

03/01/2028

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

by CTG

in Ulcerative Colitis

Other

California

Deadline:

10/27/2027

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

by CTG

in Ulcerative Colitis

Other

Alabama

Deadline:

12/01/2027

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

by CTG

in Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Indeterminate Colitis, Functional Abdominal Pain Syndrome

Other

Washington

Deadline:

01/01/2030

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

by CTG

in Ulcerative Colitis

Other

Alabama

Deadline:

07/09/2027

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

by CTG

in Obesity, Ulcerative Colitis

Other

Minnesota

Deadline:

01/01/2027

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

by CTG

in Inflammatory Bowel Disease (IBD), Ulcerative Colitis, Crohn's Disease

Other

Louisiana

Deadline:

09/30/2026

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

by CTG

in Ulcerative Colitis

Other

Arizona

Deadline:

10/01/2033

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

by CTG

in Ulcerative Colitis, Inflammatory Bowel Disease, Diet Modification

Other

California

Deadline:

12/01/2026

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

by CTG

in Ulcerative Colitis

Other

California

Deadline:

11/01/2026

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

by CTG

in Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis

Other

Alabama

Deadline:

06/30/2029

Load more All clinical trials loaded.

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Study of Novel Therapeutics for Acute Remedy of Colitis

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Ulcerative Colitis

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps